Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study

NCT00649961 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Premature Birth
Brain Injury

Interventions

DRUG: Melatonin injection

Sponsor

Imperial College London

Collaborators

[object Object]